Bihua Chen
Director, 10% Owner; Director, Chairperson and CEO, 10% Owner; Other · 6 filings · Latest: Aug 6, 2026
BlossomHill Therapeutics, Inc.
BridgeBio Oncology Therapeutics, Inc.
BRIGHT MINDS BIOSCIENCES INC.
Helix Acquisition Corp. III
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BLSM | Bihua Chen | Director, 10% Owner | Aug 10, 2026 | Purchase | $16.00 | 312,500 | $5.0M | 3,614,034 | |
DRUG | Bihua Chen | Other | Apr 28, 2026 | Sale | $89.50 | 109,331 | $9.8M | 950,000 | |
HLXC | Bihua Chen | Director, Chairperson and CEO, 10% Owner | Jan 26, 2026 | Purchase | $10.00 | 800,000 | $8.0M | 800,000 |